|
KTI12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.911620E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.257400E-01 |
| Normal-vs-Stage2 |
2.542000E-01 |
| Normal-vs-Stage3 |
6.512100E-02 |
| Normal-vs-Stage4 |
8.869600E-02 |
| Stage1-vs-Stage2 |
5.482000E-01 |
| Stage1-vs-Stage3 |
1.175430E-01 |
| Stage1-vs-Stage4 |
1.809400E-01 |
| Stage2-vs-Stage3 |
6.170200E-01 |
| Stage2-vs-Stage4 |
5.888400E-01 |
| Stage3-vs-Stage4 |
8.854400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.141400E-01 |
| Normal-vs-AfricanAmerican |
4.882200E-01 |
| Normal-vs-Asian |
4.611800E-01 |
| Caucasian-vs-AfricanAmerican |
9.121200E-01 |
| Caucasian-vs-Asian |
4.097500E-02 |
| AfricanAmerican-vs-Asian |
2.451000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.953400E-01 |
| Normal-vs-Female |
1.772000E-01 |
| Male-vs-Female |
8.212000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.505600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.628400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.610400E-02 |
| Normal-vs-Age(81-100Yrs) |
7.658400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.783600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.697190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.744200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.492400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.079200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.221600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.654500E-02 |
| Classical-VS-Follicular |
3.400300E-03 |
| Classical-VS-Other |
8.882300E-02 |
| Classical-VS-Normal |
8.414600E-01 |
| Tall-VS-Follicular |
8.818800E-01 |
| Tall-VS-Other |
5.951800E-01 |
| Tall-VS-Normal |
3.860200E-02 |
| Follicular-VS-Other |
7.139600E-01 |
| Follicular-VS-Normal |
1.480000E-02 |
| Other-VS-Normal |
9.772500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.661600E-01 |
| Normal-vs-N1 |
2.580000E-02 |
| N0-vs-N1 |
1.032980E-01 |
|
|
